Skip to main content
Equibles
CLMT logo

CLMT · Calumet, Inc. · Metrics

Track CLMT — free

Use CLMT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CLMT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$38.54 -1.10 (-2.78%) Play latest call Q3 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$3.49B
Shares
88.09M
Volume · Nov 9 718.19K Avg daily vol (3M) 1.46M

CLMT metrics

91 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$39.64
Market cap
$3.49B

Price action

23 metrics
Price change (1W)
-20.2%
Price change (30D)
-29.7%
Price change (3M)
+0.4%
Price change (6M)
+23.6%
Price change (YTD)
+99.5%
Price change (1Y)
+103.2%
Trailing year
Price change (5Y)
+245.9%
52-week high
$59.05
52-week low
$18.22
Change from 52-week high
-32.9%
Change from 52-week low
+117.6%
Annualized volatility
45.9%
Annualized volatility (3M)
57.8%
Implied volatility (30D)
63.5%
IV rank (1Y)
57.3
IV percentile (1Y)
75.1
Beta
-0.2
RSI (14D)
24.5
Price vs SMA 50
-25.8%
Price vs SMA 200
+1.3%
Avg volume (3M)
1.46M
Relative volume
2.1
Average dollar volume
$75.44M

Company

3 metrics
Sector
Basic Materials
Industry
Specialty Chemicals
Shares outstanding
88.09M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.0×
reciprocal yield 95.5%
EV / EBITDA
17.3×
reciprocal yield 5.8%
EV / EBIT
30.6×
reciprocal yield 3.3%
P / sales
0.7×
reciprocal yield 148.8%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
10.2
reciprocal yield 9.8%
Earnings yield
-5.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.0×
reciprocal yield 97.8%
EV / revenue historical average (5Y)
1.0×
reciprocal yield 97.8%
EV / EBIT historical average (3Y)
52.6×
reciprocal yield 1.9%
EV / EBIT historical average (5Y)
52.6×
reciprocal yield 1.9%
EV / EBITDA historical average (3Y)
97.7×
reciprocal yield 1.0%
EV / EBITDA historical average (5Y)
97.7×
reciprocal yield 1.0%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-11-06

Profitability

9 metrics
Gross margin
9.1%
Operating margin
3.4%
Trailing 12 months
Net margin
-3.7%
Gross profit (TTM)
$471.00M
Operating profit (TTM)
$177.90M
Net income (TTM)
−$193.80M
Trailing 12 months
Diluted EPS (TTM)
$-2.25
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$59.40
Gross profit per diluted share (TTM)
$5.34
Operating profit per diluted share (TTM)
$1.99
EBITDA per diluted share (TTM)
$3.55
Net income per diluted share (TTM)
$-2.26
Operating cash flow per diluted share (TTM)
$3.89
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.99
Book value per share
$-8.44

Growth

11 metrics
Revenue growth YoY
+56.1%
Year over year
Net income growth YoY
-18.2%
Revenue (TTM)
$5.20B
Trailing 12 months
EPS growth YoY
-19.4%
Shares change YoY
+1.3%
Year over year · more shares
Revenue CAGR (3Y)
-4.1%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-6.5%
Debt / equity
—
Current ratio
1.1
EBITDA (TTM)
$314.80M
Free cash flow (TTM)
—
Quick ratio
0.7
Interest coverage
0.9
Net debt / EBITDA
6.2
Return on invested capital
—
Trailing 12 months
Net cash
−$1.95B
Latest balance sheet
Cash & equivalents
$225.20M
Total assets
$2.99B
Total debt
$2.17B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$341.10M
Capital expenditures (TTM)
$76.00M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$86.40M
R&D / revenue
—
Stock compensation / revenue
1.7%

Ownership (13F)

9 metrics
13F filers
196
13F filer change QoQ
+7
Institutional ownership
59.0%
Conviction holders (share of 13F filers)
1.6%
Crowding (high-turnover and private-fund holders)
15.1%
Private-fund adviser ownership
13.6%
Active holders' share change QoQ
+0.8%
Holder tenure
6.4
Price vs estimated holder cost
+76.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
14.2%

Short interest

3 metrics
Short interest
4.9%
Latest settlement · 3.2 days to cover
Days to cover
3.2d
Short-squeeze score
68 / 100

Insider activity

2 metrics
Net insider buying (90D)
$0
Insider-sentiment score
47 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 2013745 CUSIP 131428104 13F (30d) 82 filings 76 filers Visit website Investor relations